Table 2.
Laboratory data just before the initiation of EV
| Variables | Overall (n = 121) | EPD vs. non-EPD | ||
|---|---|---|---|---|
| Median (range) | EPD (n = 34) | Non-EPD (n = 87) | p | |
| WBC | 6400 (3200–28,520) | 6370 (3200–28,300) | 6395 (3300–28,520) | 0.7864 |
| Neutrophil | 4192 (2851–26,780) | 4331 (2380–25,158) | 4040 (1851–12,731) | 0.4262 |
| Lymphocyte | 1258 (224–5,217) | 1332 (380–2516) | 1177 (224–5217) | 0.6159 |
| Monocyte | 428 (28–1470) | 410 (186–935) | 428 (149–1470) | 0.6322 |
| Hb | ||||
| Male | 11.6 (7–15.4) | 10.5 (7–13.6) | 11.7 (7.9–15.4) | 0.0182 |
| Female | 11.2 (7.4–14.3) | |||
| PLT 10*3 | 251 (109–595) | 269 (147–589) | 248 (109–595) | 0.125 |
| LDH | 200.5 (97–1296) | 200 (97–1296) | 200 (118–861) | 0.6022 |
| Alb | 3.8 (1.6–4.6) | 3.7 (1.6–4.5) | 3.8 (2.3–4.6) | 0.4297 |
| CRP | 1.04 (0.03–14.32) | 2.27 (0.06–14.32) | 0.62 (0.03–13.57) | 0.0889 |
| NLR at baseline | 3.5 (0.7–42) | 3.6 (1.03–17.78) | 3.3 (0.71–42) | 0.4195 |
| LMR at baseline | 2.9 (0.3–47.1) | 2.9 (0.81–6.16) | 3.0 (0.28–47.14) | 0.5759 |
| PLR at baseline | 192.8 (49–2,151.7) | 207.6 (84.9–647.6) | 193.5 (49.1–2,151.7) | 0.3384 |
Alb albumin, CRP C-reactive protein, EPD early progressive disease, Hb hemoglobin, LDH lactate dehydrogenase, LMR lymphocyte/monocyte ratio, NLR neutrophil/lymphocyte ratio, PLT platelet, PLT/LMR platelet/lymphocyte ratio, WBC white blood cell